• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PD-L1 和 LAG-3 的治疗性阻断可迅速清除已建立的血期疟原虫感染。

Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection.

机构信息

Department of Microbiology, University of Iowa, Iowa City, Iowa, USA.

出版信息

Nat Immunol. 2011 Dec 11;13(2):188-95. doi: 10.1038/ni.2180.

DOI:10.1038/ni.2180
PMID:22157630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3262959/
Abstract

Infection of erythrocytes with Plasmodium species induces clinical malaria. Parasite-specific CD4(+) T cells correlate with lower parasite burdens and severity of human malaria and are needed to control blood-stage infection in mice. However, the characteristics of CD4(+) T cells that determine protection or parasite persistence remain unknown. Here we show that infection of humans with Plasmodium falciparum resulted in higher expression of the inhibitory receptor PD-1 associated with T cell dysfunction. In vivo blockade of the PD-1 ligand PD-L1 and the inhibitory receptor LAG-3 restored CD4(+) T cell function, amplified the number of follicular helper T cells and germinal-center B cells and plasmablasts, enhanced protective antibodies and rapidly cleared blood-stage malaria in mice. Thus, chronic malaria drives specific T cell dysfunction, and proper function can be restored by inhibitory therapies to enhance parasite control.

摘要

疟原虫感染红细胞会引发临床疟疾。疟原虫特异性 CD4(+) T 细胞与较低的寄生虫载量和人类疟疾的严重程度相关,是控制小鼠血液阶段感染所必需的。然而,决定保护或寄生虫持续存在的 CD4(+) T 细胞特征仍然未知。本文中,作者表明,感染疟原虫会导致与 T 细胞功能障碍相关的抑制性受体 PD-1 表达升高。在体内阻断 PD-1 配体 PD-L1 和抑制性受体 LAG-3 可恢复 CD4(+) T 细胞功能,扩增滤泡辅助 T 细胞和生发中心 B 细胞和浆母细胞的数量,增强保护性抗体,并迅速清除小鼠的血液阶段疟疾。因此,慢性疟疾会导致特定的 T 细胞功能障碍,通过抑制性治疗恢复适当的功能可以增强寄生虫的控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/26184d7d5fbe/nihms-334577-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/23770dd5818e/nihms-334577-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/e07593db5470/nihms-334577-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/2a55637cecbc/nihms-334577-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/09630ce6e26d/nihms-334577-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/ee8194805e94/nihms-334577-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/26184d7d5fbe/nihms-334577-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/23770dd5818e/nihms-334577-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/e07593db5470/nihms-334577-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/2a55637cecbc/nihms-334577-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/09630ce6e26d/nihms-334577-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/ee8194805e94/nihms-334577-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4933/3262959/26184d7d5fbe/nihms-334577-f0006.jpg

相似文献

1
Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection.PD-L1 和 LAG-3 的治疗性阻断可迅速清除已建立的血期疟原虫感染。
Nat Immunol. 2011 Dec 11;13(2):188-95. doi: 10.1038/ni.2180.
2
Blockade of LAG-3 in PD-L1-Deficient Mice Enhances Clearance of Blood Stage Malaria Independent of Humoral Responses.阻断 LAG-3 可增强 PD-L1 缺陷型小鼠对血期疟原虫的清除作用,不依赖于体液免疫反应。
Front Immunol. 2021 Jan 14;11:576743. doi: 10.3389/fimmu.2020.576743. eCollection 2020.
3
A new therapeutic strategy for malaria: targeting T cell exhaustion.疟疾的新治疗策略:针对 T 细胞耗竭。
Nat Immunol. 2012 Jan 19;13(2):113-5. doi: 10.1038/ni.2211.
4
Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease.分析 COVID-19 感染与急性疟疾中抑制性受体的表达:LAG-3 和 TIM-3 与 T 细胞激活和疾病过程相关。
Front Immunol. 2020 Aug 26;11:1870. doi: 10.3389/fimmu.2020.01870. eCollection 2020.
5
Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion.慢性疟原虫感染与 B 和 T 细胞耗竭的表型证据有关。
J Immunol. 2013 Feb 1;190(3):1038-47. doi: 10.4049/jimmunol.1202438. Epub 2012 Dec 21.
6
T cells expressing multiple co-inhibitory molecules in acute malaria are not exhausted but exert a suppressive function in mice.在急性疟疾中表达多种共抑制分子的 T 细胞并未衰竭,而是在小鼠中发挥抑制功能。
Eur J Immunol. 2022 Feb;52(2):312-327. doi: 10.1002/eji.202149424. Epub 2021 Nov 25.
7
Differential expression pattern of co-inhibitory molecules on CD4 T cells in uncomplicated versus complicated malaria.CD4 T 细胞共抑制分子在单纯性疟疾与复杂性疟疾中的差异表达模式。
Sci Rep. 2018 Mar 19;8(1):4789. doi: 10.1038/s41598-018-22659-1.
8
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity.程序性死亡受体-1 配体 2 调节 PD-L1 与 PD-1 轴对于建立 CD4(+) T 细胞免疫至关重要。
Immunity. 2016 Aug 16;45(2):333-45. doi: 10.1016/j.immuni.2016.07.017.
9
CD28 deficiency leads to accumulation of germinal-center independent IgM+ experienced B cells and to production of protective IgM during experimental malaria.CD28 缺陷导致生发中心非依赖型 IgM+记忆 B 细胞的积累,并在实验性疟疾中产生保护性 IgM。
PLoS One. 2018 Aug 27;13(8):e0202522. doi: 10.1371/journal.pone.0202522. eCollection 2018.
10
The T-Cell Inhibitory Molecule Butyrophilin-Like 2 Is Up-regulated in Mild Plasmodium falciparum Infection and Is Protective During Experimental Cerebral Malaria.T细胞抑制分子类嗜乳脂蛋白2在轻度恶性疟原虫感染中上调,并在实验性脑型疟期间具有保护作用。
J Infect Dis. 2015 Oct 15;212(8):1322-31. doi: 10.1093/infdis/jiv217. Epub 2015 Apr 15.

引用本文的文献

1
CD155 as a therapeutic target in alveolar echinococcosis: insights from an infection mouse model.CD155作为肺泡型包虫病的治疗靶点:来自感染小鼠模型的见解
Front Microbiol. 2025 Jul 1;16:1624387. doi: 10.3389/fmicb.2025.1624387. eCollection 2025.
2
Therapeutic potential of targeting LAG-3 in cancer.靶向淋巴细胞活化基因3(LAG-3)在癌症治疗中的潜力。
J Immunother Cancer. 2025 Jul 8;13(7):e011652. doi: 10.1136/jitc-2025-011652.
3
Biologically targeted dual adaptive and innate nano-Immunotherapy for clear cell renal cell carcinoma treatment.

本文引用的文献

1
Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think.定量病毒感染期间的抗原特异性 CD4 T 细胞:CD4 T 细胞反应比我们想象的要大。
J Immunol. 2011 Dec 1;187(11):5568-76. doi: 10.4049/jimmunol.1102104. Epub 2011 Oct 31.
2
Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1.免疫逃避:疟原虫感染红细胞表面 PfEMP1 暴露的保护性 IgG 表位被 IgM 掩盖导致恶性疟原虫疟疾
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12485-90. doi: 10.1073/pnas.1103708108. Epub 2011 Jul 11.
3
用于透明细胞肾细胞癌治疗的生物靶向双重适应性和先天性纳米免疫疗法。
Mol Cancer. 2025 Jun 18;24(1):181. doi: 10.1186/s12943-025-02382-y.
4
Immunomodulatory effects of Eimeria maxima surface antigen (EmSAG) as an IFN-γ inhibitory molecule on peripheral blood mononuclear cells (PBMCs) and T cell subsets in chickens.巨型艾美耳球虫表面抗原(EmSAG)作为一种干扰素-γ抑制分子对鸡外周血单个核细胞(PBMC)和T细胞亚群的免疫调节作用
Vet Res. 2025 May 19;56(1):103. doi: 10.1186/s13567-025-01535-7.
5
LAG3 regulates antibody responses in a murine model of kidney transplantation.LAG3在肾移植小鼠模型中调节抗体反应。
J Clin Invest. 2025 May 13;135(13). doi: 10.1172/JCI172988. eCollection 2025 Jul 1.
6
Regulatory T cell memory: implications for malaria.调节性T细胞记忆:对疟疾的影响
J Immunol. 2025 Aug 1;214(8):1872-1880. doi: 10.1093/jimmun/vkaf067.
7
Systemic 4-1BB stimulation augments extrafollicular memory B cell formation and recall responses during Plasmodium infection.全身性4-1BB刺激可增强疟原虫感染期间滤泡外记忆B细胞的形成和回忆反应。
Cell Rep. 2025 Apr 22;44(4):115528. doi: 10.1016/j.celrep.2025.115528. Epub 2025 Apr 11.
8
Malaria: Factors affecting disease severity, immune evasion mechanisms, and reversal of immune inhibition to enhance vaccine efficacy.疟疾:影响疾病严重程度的因素、免疫逃避机制以及逆转免疫抑制以提高疫苗效力
PLoS Pathog. 2025 Jan 23;21(1):e1012853. doi: 10.1371/journal.ppat.1012853. eCollection 2025 Jan.
9
Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy.利用细菌制剂调节肿瘤微环境并增强癌症免疫疗法。
Cancers (Basel). 2024 Nov 13;16(22):3810. doi: 10.3390/cancers16223810.
10
Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage non-lethal infection.协同阻断 TIGIT 和 PD-L1 可增加 1 型炎症反应,并改善非致死性血期感染期间寄生虫的控制。
Infect Immun. 2024 Nov 12;92(11):e0034524. doi: 10.1128/iai.00345-24. Epub 2024 Sep 26.
T cell exhaustion.
T 细胞耗竭。
Nat Immunol. 2011 Jun;12(6):492-9. doi: 10.1038/ni.2035.
4
Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites.经晚期肝脏阶段抑制遗传减毒寄生虫疫苗接种后获得的抗疟免疫力更高。
Cell Host Microbe. 2011 Jun 16;9(6):451-62. doi: 10.1016/j.chom.2011.05.008.
5
Responsiveness of HIV-specific CD4 T cells to PD-1 blockade.HIV 特异性 CD4 T 细胞对 PD-1 阻断的反应性。
Blood. 2011 Jul 28;118(4):965-74. doi: 10.1182/blood-2010-12-328070. Epub 2011 Jun 7.
6
Protective capacity of memory CD8+ T cells is dictated by antigen exposure history and nature of the infection.记忆性 CD8+ T 细胞的保护能力取决于抗原暴露史和感染的性质。
Immunity. 2011 May 27;34(5):781-93. doi: 10.1016/j.immuni.2011.03.020. Epub 2011 May 5.
7
Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells.病毒持续存在将 CD4 T 细胞分化转向滤泡辅助性 T 细胞。
J Exp Med. 2011 May 9;208(5):987-99. doi: 10.1084/jem.20101773. Epub 2011 May 2.
8
Follicular helper CD4 T cells (TFH).滤泡辅助性 CD4 T 细胞(TFH)。
Annu Rev Immunol. 2011;29:621-63. doi: 10.1146/annurev-immunol-031210-101400.
9
CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition.CD4 T 细胞在缺乏 PD-1 介导的抑制的情况下促进而不是控制结核病。
J Immunol. 2011 Feb 1;186(3):1598-607. doi: 10.4049/jimmunol.1003304. Epub 2010 Dec 20.
10
Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer.作为癌症免疫疗法的阻断PD1通路单克隆抗体的临床开发。
Curr Opin Investig Drugs. 2010 Dec;11(12):1354-9.